Pub Date : 2020-11-01DOI: 10.1016/j.brain.2020.100018
David B. MacManus , Andrea Menichetti , Bart Depreitere , Nele Famaey , Jos Vander Sloten , Michael Gilchrist
The regional dynamic mechanical properties of mouse, rat, pig, and human brain tissue were compared directly in this first-of-its-kind study. Our results suggest the use of pig or mouse brain tissue as suitable surrogates to characterise human brain tissue. The importance of this work is highlighted by the extensive use of constitutive data from animal brain tissue in traumatic brain injury research in the absence of human brain tissue data without any direct evidence supporting their use. Indentation force-relaxation experiments were performed on mouse, rat, pig, and human brains at 10/s strain rate up to 35% strain to determine the dynamic mechanical properties of brain tissue. Finite element models have become useful tools to investigate the biomechanics of traumatic brain injury - a global leading cause of death and disability and a risk factor for developing neurodegenerative diseases. However, these models require accurate constitutive data for brain tissue to produce reliable results. The results presented here provide validation for the use of pig and mouse brain tissue data in such models.
Statement of Significance
The significance of this work is underscored by the extensive use of animal brain tissue as a surrogate for human brain tissue without any direct evidence supporting the validity of their use. For the first time ever, we demonstrate that porcine and murine brain tissue can be used as surrogates for human brain tissue under dynamic loading conditions. These findings will allow researchers to select appropriate animal surrogates for human brain tissue under dynamic loading conditions. Furthermore, our findings support the use of animal surrogate data to improve the fidelity of computational models of the human brain, and provide experimental data to develop constitutive models of brain tissue.
{"title":"Towards animal surrogates for characterising large strain dynamic mechanical properties of human brain tissue","authors":"David B. MacManus , Andrea Menichetti , Bart Depreitere , Nele Famaey , Jos Vander Sloten , Michael Gilchrist","doi":"10.1016/j.brain.2020.100018","DOIUrl":"10.1016/j.brain.2020.100018","url":null,"abstract":"<div><p>The regional dynamic mechanical properties of mouse, rat, pig, and human brain tissue were compared directly in this first-of-its-kind study. Our results suggest the use of pig or mouse brain tissue as suitable surrogates to characterise human brain tissue. The importance of this work is highlighted by the extensive use of constitutive data from animal brain tissue in traumatic brain injury research in the absence of human brain tissue data without any direct evidence supporting their use. Indentation force-relaxation experiments were performed on mouse, rat, pig, and human brains at 10/s strain rate up to 35% strain to determine the dynamic mechanical properties of brain tissue. Finite element models have become useful tools to investigate the biomechanics of traumatic brain injury - a global leading cause of death and disability and a risk factor for developing neurodegenerative diseases. However, these models require accurate constitutive data for brain tissue to produce reliable results. The results presented here provide validation for the use of pig and mouse brain tissue data in such models.</p></div><div><h3>Statement of Significance</h3><p>The significance of this work is underscored by the extensive use of animal brain tissue as a surrogate for human brain tissue without any direct evidence supporting the validity of their use. For the first time ever, we demonstrate that porcine and murine brain tissue can be used as surrogates for human brain tissue under dynamic loading conditions. These findings will allow researchers to select appropriate animal surrogates for human brain tissue under dynamic loading conditions. Furthermore, our findings support the use of animal surrogate data to improve the fidelity of computational models of the human brain, and provide experimental data to develop constitutive models of brain tissue.</p></div>","PeriodicalId":72449,"journal":{"name":"Brain multiphysics","volume":"1 ","pages":"Article 100018"},"PeriodicalIF":0.0,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.brain.2020.100018","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"93721391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2016-11-03DOI: 10.1002/14651858.CD004832.pub4
Charalampos S Siristatidis, George Basios, Vasilios Pergialiotis, Paraskevi Vogiatzi
<p><strong>Background: </strong>Aspirin is used with the aim of optimising the chance of live birth in women undergoing assisted reproductive technology (ART), despite inconsistent evidence of its efficacy and safety (in terms of intraoperative bleeding during oocyte retrieval and risk of miscarriage). The most appropriate time to commence aspirin therapy and the length of treatment required are also still to be determined. This is the second update of the review first published in 2007.</p><p><strong>Objectives: </strong>To evaluate the effectiveness and safety of aspirin in women undergoing ART.</p><p><strong>Search methods: </strong>We searched the Cochrane Gynaecology and Fertility Group Trials Register, Cochrane Central Register of Controlled Trials (CENTRAL; 2016, Issue 4) in the Cochrane Library (searched 9 May 2016); the databases MEDLINE (1946 to 9 May 2016) and Embase (1974 to 9 May 2016); and trial registers (ClinicalTrials.gov and the World Health Organization International Clinical Trials Registry Platform search portal). We also examined the reference lists of all known primary studies and review articles, citation lists of relevant publications and abstracts of major scientific meetings, combined with the Cochrane Gynaecology and Fertility Group's search strategy.</p><p><strong>Selection criteria: </strong>Randomised controlled trials on aspirin for women undergoing ART.</p><p><strong>Data collection and analysis: </strong>Two review authors independently assessed trial eligibility and risk of bias and extracted the data. The primary review outcome was live birth. Secondary outcomes included clinical pregnancy, ongoing pregnancy, multiple pregnancy, miscarriage, and other complications associated with IVF/ICSI or with pregnancy and birth. We combined data to calculate risk ratios (RRs) (for dichotomous data) and mean differences (MDs) (for continuous data) and 95% confidence intervals (CIs). Statistical heterogeneity was assessed using the I² statistic. We assessed the overall quality of the evidence for the main comparisons using GRADE methods.</p><p><strong>Main results: </strong>The search identified 13 trials as eligible for inclusion in the review, including a total of 2653 participants with a mean age of 35 years. Ten studies used a dose of 100 mg and three used 80 mg of aspirin per day. In most of them, aspirin was commenced immediately at the start of down-regulation, while the duration of treatment varied widely. Eight studies provided a placebo for the control group.There was no evidence of a difference between the aspirin group and the group receiving no treatment or placebo in rates of live birth (RR 0.91, 95% CI 0.72 to 1.15, 3 RCTs, n = 1053, I² = 15%, moderate-quality evidence). In addition, clinical pregnancy rates were also similar for the two groups (RR 1.03, 95% CI 0.91 to 1.17, 10 RCTs, n = 2142, I² = 27%, moderate-quality evidence); sensitivity analysis, excluding studies at high risk of bias, did not change th
背景:使用阿司匹林的目的是为了提高接受辅助生殖技术(ART)的妇女活产的几率,尽管有关其疗效和安全性(卵母细胞提取术中出血和流产风险)的证据并不一致。开始阿司匹林治疗的最合适时间和所需治疗时间也仍有待确定。本文是对 2007 年首次发表的综述的第二次更新:评估阿司匹林对接受抗逆转录病毒疗法妇女的有效性和安全性:我们检索了科克伦图书馆(2016年5月9日检索)中的科克伦妇科和不孕不育组试验登记册、科克伦对照试验中央登记册(CENTRAL;2016年第4期);数据库MEDLINE(1946年至2016年5月9日)和Embase(1974年至2016年5月9日);以及试验登记册(ClinicalTrials.gov和世界卫生组织国际临床试验登记平台搜索门户)。我们还检查了所有已知主要研究和综述文章的参考文献目录、相关出版物的引文目录以及主要科学会议的摘要,并结合了 Cochrane 妇科和不孕不育小组的检索策略:数据收集与分析:两位综述作者独立评估试验资格和偏倚风险,并提取数据。主要审查结果为活产。次要结果包括临床妊娠、持续妊娠、多胎妊娠、流产以及与体外受精/卵胞浆内单精子显微注射相关或与妊娠和分娩相关的其他并发症。我们结合数据计算风险比 (RRs)(二分法数据)和平均差 (MDs)(连续法数据)以及 95% 置信区间 (CIs)。统计异质性采用 I² 统计量进行评估。我们采用 GRADE 方法评估了主要比较证据的总体质量:通过检索,我们发现有 13 项试验符合纳入综述的条件,共有 2653 名参与者,平均年龄为 35 岁。十项研究使用的阿司匹林剂量为每天 100 毫克,三项研究使用的剂量为每天 80 毫克。在大多数研究中,阿司匹林都是在开始降调节时立即开始服用,而治疗持续时间则差别很大。没有证据表明阿司匹林组与未接受治疗或安慰剂组在活产率方面存在差异(RR 0.91,95% CI 0.72 至 1.15,3 项 RCT,n = 1053,I² = 15%,中等质量证据)。此外,两组的临床妊娠率也相似(RR 1.03,95% CI 0.91 至 1.17,10 项 RCT,n = 2142,I² = 27%,中等质量证据);敏感性分析排除了偏倚风险较高的研究,但并未改变效应估计值。没有证据表明,经超声证实的多胎妊娠(RR 0.67,95% CI 0.37 至 1.25,2 项 RCT,n = 656,I² = 0%,低质量证据)、流产(RR 1.10,95% CI 0.68 至 1.77,5 项 RCT,n = 2142,I² = 27%,中质量证据)在组间存在差异。77, 5 RCTs, n = 1497, I² = 0%, 低质量证据)、宫外孕(RR 1.86, 95% CI 0.75 to 4.63, 3 RCTs, n = 1135, I² = 0%, 低质量证据)或阴道出血(RR 1.01, 95% CI 0.14 to 7.13, 1 RCTs, n = 487, 低质量证据)。证据的总体质量从极低到中等不等;局限性在于研究方法的报告较少,并怀疑存在发表偏倚:目前没有证据表明常规使用阿司匹林可提高普通试管婴儿的妊娠率。这是基于随机对照试验的现有数据,目前没有证据表明阿司匹林对接受 ART 的妇女有影响,因为没有单一的结果指标能证明使用阿司匹林有好处。此外,目前的证据并不排除不良反应的可能性。
{"title":"Aspirin for in vitro fertilisation.","authors":"Charalampos S Siristatidis, George Basios, Vasilios Pergialiotis, Paraskevi Vogiatzi","doi":"10.1002/14651858.CD004832.pub4","DOIUrl":"10.1002/14651858.CD004832.pub4","url":null,"abstract":"<p><strong>Background: </strong>Aspirin is used with the aim of optimising the chance of live birth in women undergoing assisted reproductive technology (ART), despite inconsistent evidence of its efficacy and safety (in terms of intraoperative bleeding during oocyte retrieval and risk of miscarriage). The most appropriate time to commence aspirin therapy and the length of treatment required are also still to be determined. This is the second update of the review first published in 2007.</p><p><strong>Objectives: </strong>To evaluate the effectiveness and safety of aspirin in women undergoing ART.</p><p><strong>Search methods: </strong>We searched the Cochrane Gynaecology and Fertility Group Trials Register, Cochrane Central Register of Controlled Trials (CENTRAL; 2016, Issue 4) in the Cochrane Library (searched 9 May 2016); the databases MEDLINE (1946 to 9 May 2016) and Embase (1974 to 9 May 2016); and trial registers (ClinicalTrials.gov and the World Health Organization International Clinical Trials Registry Platform search portal). We also examined the reference lists of all known primary studies and review articles, citation lists of relevant publications and abstracts of major scientific meetings, combined with the Cochrane Gynaecology and Fertility Group's search strategy.</p><p><strong>Selection criteria: </strong>Randomised controlled trials on aspirin for women undergoing ART.</p><p><strong>Data collection and analysis: </strong>Two review authors independently assessed trial eligibility and risk of bias and extracted the data. The primary review outcome was live birth. Secondary outcomes included clinical pregnancy, ongoing pregnancy, multiple pregnancy, miscarriage, and other complications associated with IVF/ICSI or with pregnancy and birth. We combined data to calculate risk ratios (RRs) (for dichotomous data) and mean differences (MDs) (for continuous data) and 95% confidence intervals (CIs). Statistical heterogeneity was assessed using the I² statistic. We assessed the overall quality of the evidence for the main comparisons using GRADE methods.</p><p><strong>Main results: </strong>The search identified 13 trials as eligible for inclusion in the review, including a total of 2653 participants with a mean age of 35 years. Ten studies used a dose of 100 mg and three used 80 mg of aspirin per day. In most of them, aspirin was commenced immediately at the start of down-regulation, while the duration of treatment varied widely. Eight studies provided a placebo for the control group.There was no evidence of a difference between the aspirin group and the group receiving no treatment or placebo in rates of live birth (RR 0.91, 95% CI 0.72 to 1.15, 3 RCTs, n = 1053, I² = 15%, moderate-quality evidence). In addition, clinical pregnancy rates were also similar for the two groups (RR 1.03, 95% CI 0.91 to 1.17, 10 RCTs, n = 2142, I² = 27%, moderate-quality evidence); sensitivity analysis, excluding studies at high risk of bias, did not change th","PeriodicalId":72449,"journal":{"name":"Brain multiphysics","volume":"1 1","pages":"CD004832"},"PeriodicalIF":0.0,"publicationDate":"2016-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463901/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76263389","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.1016/j.brain.2023.100075
P. Bayly
{"title":"Perspective: Challenges and opportunities in computational brain mechanics research: How can we use recent experimental data to improve models of brain mechanics?","authors":"P. Bayly","doi":"10.1016/j.brain.2023.100075","DOIUrl":"https://doi.org/10.1016/j.brain.2023.100075","url":null,"abstract":"","PeriodicalId":72449,"journal":{"name":"Brain multiphysics","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54406268","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.1016/j.brain.2023.100077
M. Ramzanpour, Bahram Jafari, Jeremy L. Smith, Jason Allen, M. Hajiaghamemar
{"title":"Comprehensive study of sex-based anatomical variations of human brain and development of sex-specific brain templates","authors":"M. Ramzanpour, Bahram Jafari, Jeremy L. Smith, Jason Allen, M. Hajiaghamemar","doi":"10.1016/j.brain.2023.100077","DOIUrl":"https://doi.org/10.1016/j.brain.2023.100077","url":null,"abstract":"","PeriodicalId":72449,"journal":{"name":"Brain multiphysics","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54406365","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.1016/j.brain.2023.100076
S. Budday
{"title":"Exploring human brain mechanics by combining experiments, modeling, and simulation","authors":"S. Budday","doi":"10.1016/j.brain.2023.100076","DOIUrl":"https://doi.org/10.1016/j.brain.2023.100076","url":null,"abstract":"","PeriodicalId":72449,"journal":{"name":"Brain multiphysics","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54406294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}